TLR4 and Barrett esophagus: Furthermore, microbiome-mediated inflammation may accelerate BE progression via lipopolysaccharide (LPS)-mediated activation of Toll-like receptor 4 (TLR-4), which leads to IL-18 production and pro-inflammatory cascades [36].